Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
Titel:
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
Auteur:
Gallant, Joel Lazzarin, Adriano Mills, Anthony Orkin, Chloe Podzamczer, Daniel Tebas, Pablo Girard, Pierre-Marie Brar, Indira Daar, Eric S Wohl, David Rockstroh, Jürgen Wei, Xuelian Custodio, Joseph White, Kirsten Martin, Hal Cheng, Andrew Quirk, Erin